Skip to main content

Animations

MJFF Publications

5291 - 5300 of 8823 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohort
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00919-y
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Hyposmia in Parkinson’s disease; exploring selective odour loss
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00922-3
    Citation Count: 6
  • Summary Details
    OPEN
    Title: LRRK2 -associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf103
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf146
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Longitudinal neuromelanin changes in prodromal and early Parkinson’s disease in humans and rat model
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf204
    Citation Count: 6
  • Summary Details
    OPEN
    Title: The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241310722
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Iron deposition is associated with motor and non-motor network breakdown in parkinsonism
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2024.1518155
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Agricultural copper pesticide exposure and DNA methylation in Central Valley of California residents with and without Parkinson's disease
    Journal Name: Environmental Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.envres.2025.122335
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Longitudinal Assessment of Parkinson’s Motor Symptoms and Dopaminergic Dysfunction Patterns Using DaTSCAN
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100331
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Pregnenolone Reduces L‐Dopa‐Induced Dyskinesias in Female Parkinsonian Monkeys
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30280
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.